SEEKYO
Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies By targeting the microenvironment of solid tumors while sparing healthy tissues, our aim is to provide treatments without adverse effects to cancer patients. Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignant specificities thanks to its targeting unit and allow the controlled release of the parent drug exclusively at the tumour site, based on its versatile enzyme-responsive self-immolative linker.
SEEKYO
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2018-01-01
Address:
Poitiers, Poitou-Charentes, France
Country:
France
Website Url:
http://www.seekyo-therapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.45 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Maps JsDelivr Cloudflare JS CDN JS CloudFront
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Rectify Pharmaceuticals
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Seed Round - Seekyo
European Investment Fund
European Investment Fund investment in Debt Financing - Seekyo
French Tech Acceleration Fund
French Tech Acceleration Fund investment in Seed Round - Seekyo
Official Site Inspections
http://www.seekyo-therapeutics.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Seekyo"
Seekyo - Crunchbase Company Profile & Funding
Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies. By targeting the microenvironment of solid tumors while sparing healthy …See details»
Seekyo 2025 Company Profile: Valuation, Funding & Investors
Www.seekyo-therapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Technopole Grand Poitiers Site CEI bat Téléport 1; …See details»
SEEKYO Company Profile - Office Locations, Competitors, Revenue …
SEEKYO has 5 employees across 2 locations and $720.47 k in total funding,. See insights on SEEKYO including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Seekyo Company Profile: Overview and Full News Analysis
Seekyo is a company based in Poitou-Charentes that operates in the field of Tumor Activated Therapy, focusing on developing targeted therapies for solid cancers. Seekyo's Tumor …See details»
Seekyo Therapeutics: Contact Details and Business Profile
Seekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: TUMOR ACTIVATED THERAPY We aim at a high selectivity in the treatment for solid …See details»
Seekyo - Poitiers, France
Jan 22, 2020 SEEKYO® is a privately-owned biotech company developing the next generation of chemotherapies, providing cancer patient efficient treatment without adverse effects. We …See details»
SEEKYO Therapeutics - VentureRadar
Halozyme Therapeutics, Inc. USA Publicly Traded Halozyme is a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the …See details»
SEEKYO Therapeutics - gust.com
SEEKYO Therapeutics Seekyo est une société de biotechnologie développant la prochaine génération de chimiothérapies: limiter les effets indésirables et améliorer la qualité de vie. …See details»
Seekyo - Medtech Alert
Mar 28, 2022 Seekyo is a biotechnology startup developing new-generation cancer treatments, known as ‘smart chemotherapy’ selective to tumors, reducing adverse effects from standard …See details»
Publications | Seekyo - Seekyo Therapeutics
Targeting the tumor microenvironment hallmarks for pancreas and breast (TN) cancers chemotherapySee details»
Events | Seekyo - seekyo-therapeutics.com
Sachs' 23rd Annual Biotech Forum Sept 2023 (Basel, Switzerland) Discover. Bio€quity Europe, May 2022 (Milano, Italy)See details»
Seekyo ou la chimiothérapie de demain - YouTube
Webinar de présentation de la start-up Seekyo Therapeutics (Poitiers, 86). Comment limiter les effets secondaires des traitements anticancéreux ?Comment aid...See details»
Seekyo | EU-Startups
Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignant specificities thanks to its targeting unit and …See details»
Biotech start-up Seekyo raises €800k with leverage from
Poitiers, France, January 20, 2020 – Seekyo, a privately-owned biotech start-up specializing in the development of the next generation of chemotherapies, announces today that it has …See details»
News - Seekyo
In the Press: Seekyo's CEO sharing his perspective with Drug Discovery World (Feb 2025) Discover. Seekyo is adding diagnostics and theranostics capabilities to its lead compound …See details»
Seekyo raises €800k from French tech seed fund
Image credits- seekyo therapeutics. France based Seekyo, a privately-owned biotech start-up specializing in the development of the next generation of chemotherapies, announces that it …See details»
Seekyo raises over €650,000 from business angels and Bpifrance
Poitiers, France, March 17, 2021 – Seekyo, a startup company specializing in developing smart chemotherapy drugs, today announces that it has raised in excess of €650,000 ($775K) in …See details»
Biotech start-up Seekyo raises €800k with leverage from
The funds will allow the company to accelerate the development of its chemotherapy drug candidate targeting solid tumorsSee details»
Seekyo Therapeutics on LinkedIn: Seekyo Therapeutics's team is ...
Seekyo Therapeutics's team is delighted to continue reinforcing the internal expertise towards the preclinical and clinical phases with Dr Anke Domdey, MSc Pharm, PhD's recent additionSee details»